CLASS II Device recall · Reported 1 Oct 2014 · FDA Enforcement Report

Vitros Immunodiagnostic Products Anti-HCV Reagent Pack recalled

Ortho-clinical Diagnostics is recalling Vitros Immunodiagnostic Products Anti-HCV Reagent Pack for in vitro qualitative detection, distributed in 9 states. The recall was initiated on 6 Aug 2014 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesLot 9090 (exp. December 15, 2014)
Quantity recalled463 sales units

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-2671-2014
FDA event ID
68974
Recalling firm
Ortho-clinical Diagnostics, Bridgend, N/A
Classification
Class II
Status
Terminated
Recall initiated
6 Aug 2014
FDA classified
19 Sep 2014
Reported
1 Oct 2014
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Other Reasons

Timeline

6 Aug 2014Recall initiated by company
19 Sep 2014Classified by FDA+44 days
1 Oct 2014Published in enforcement report+12 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

VITROS Immunodiagnostic Products Anti-HCV kit lot 9090 has been observed producing sporadic lower than expected VITROS Anti-HCV test results due to an approximate signal loss of up to 66.2% which can result in unexpected negative test results being obtained for reactive sample fluids (quality control and patient samples).

Product as listed by the FDA

VITROS Immunodiagnostic Products Anti-HCV Reagent Pack for in vitro qualitative detection of immunoglobulin G antibody to hepatitis C virus (anti-HCV) in human serum and plasma. REF 680 2454, IVD -- Ortho-Clinical Diagnostics High Wycombe UK. Note that one sales unit has 5 Reagent Packs contained within it. Each Reagent Pack can test for 100 samples (patient, Quality Control, etc.).

Where it was distributed

NY, NJ, CT, MA, PA, VA, MD, FL and GA

ConnecticutFloridaGeorgiaMassachusettsMarylandNew JerseyNew YorkPennsylvaniaVirginia

Questions about this recall

Why was it recalled?

VITROS Immunodiagnostic Products Anti-HCV kit lot 9090 has been observed producing sporadic lower than expected VITROS Anti-HCV test results due to an approximate signal loss of up to 66.2% which can result in unexpected negative test results being obtained for reactive sample fluids (quality control and patient samples).

Which lots are affected?

Lot 9090 (exp. December 15, 2014)

Where was it sold?

NY, NJ, CT, MA, PA, VA, MD, FL and GA

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Ortho-clinical Diagnostics

All 311

Other Test Kits & Diagnostics recalls

All 2,656